Antinnate Therapeutics is a spin-off of the Radboud University Nijmegen Medical Centre. The main focus is to develop novel therapeutics for infectious, auto-inflammatory and autoimmune diseases. The company is currently developing a potent TLR4 antagonist for rheumatoid arthritis (RA) and cardiovascular diseases.
Lifesciences@Work : We help scientists build their business